Stem Cells Without Borders: What’s Legal, What’s Promising & What You Need to Know

Stem cells are being used and marketed around the world—but what’s actually allowed, what does the science say, and how can patients separate promising regenerative medicine from expensive hype?

On this episode of Sugar Crush: The Rest of the Story, Dr. Rick Jacoby welcomes an unusual co-host - “Chat" - for a wide-ranging conversation about the evolving world of stem cells and regenerative medicine.

Dr. Rick explores the differences between FDA Sections 351 and 361, minimally manipulated tissue, homologous use, Wharton’s jelly, emerging MUSE cells, PRP, bone marrow-derived treatments, and other regenerative approaches. The conversation also goes global, comparing regulatory environments in the United States, Canada, Mexico, the United Kingdom, Japan, Panama, and beyond. 

They also tackle the booming world of stem-cell medical tourism: Why do patients travel internationally for treatment? Does a higher price mean a better therapy? What questions should consumers ask before choosing a clinic? And how can patients distinguish between what’s being advertised and what has actually been demonstrated through research? 

Finally, Dr. Rick shares his own experiences with regenerative treatments and looks at the continuum from PRP and traditional approaches to newer cell-based therapies—while emphasizing the importance of understanding the evidence, regulatory status, potential costs, and available options before making a decision. 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.